Nechama Sharon
- Infectious Diseases top 5%
- Immunology
- Molecular Biology
- Health top 10%
- Neurology
- Co-authors
- Moshe ShasharIdit F. SchwartzDoron SchwartzTalya FinnRegev CohenAyelet GrupperM. PollardAmos Toren
- Topics
- Platelet Disorders and Treatments (4 papers)Herpesvirus Infections and Treatments (4 papers)Blood groups and transfusion (4 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Nechama Sharon
31 papers receiving 535 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Infectious Diseases 267
- Immunology 104
- Molecular Biology 84
- Health 60
- Neurology 59
Countries citing papers authored by Nechama Sharon
This map shows the geographic impact of Nechama Sharon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nechama Sharon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nechama Sharon more than expected).
Fields of papers citing papers by Nechama Sharon
This network shows the impact of papers produced by Nechama Sharon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nechama Sharon. The network helps show where Nechama Sharon may publish in the future.
Co-authorship network of co-authors of Nechama Sharon
This figure shows the co-authorship network connecting the top 25 collaborators of Nechama Sharon. A scholar is included among the top collaborators of Nechama Sharon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nechama Sharon. Nechama Sharon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Clinical Outcomes and Laboratory Values of Infants with COVID-19 among Several Maternal Variables: A Retrospective Cohort. | 1 |
| 3 | 0 | |
| 4 | Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysisbreakdown → | 224 |
| 5 | 3 | |
| 6 | 18 | |
| 7 | 15 | |
| 8 | 4 | |
| 9 | 9 | |
| 10 | Transient lymphopenia and neutropenia: pediatric influenza A/H1N1 infection in a primary hospital in Israel. | 10 |
| 11 | 5 | |
| 12 | 16 | |
| 13 | 35 | |
| 14 | 2 | |
| 15 | 26 | |
| 16 | 12 | |
| 17 | 4 | |
| 18 | 4 | |
| 19 | 16 | |
| 20 | 1 |
About Nechama Sharon
Nechama Sharon is a scholar working on Hematology, Dermatology and Microbiology, having authored 34 papers that have together received 562 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (4 papers), Herpesvirus Infections and Treatments (4 papers) and Blood groups and transfusion (4 papers). The work is most often cited by research in Infectious Diseases (267 citations), Health (60 citations) and Modeling and Simulation (24 citations). Nechama Sharon has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Moshe Shashar, Idit F. Schwartz, Doron Schwartz, Talya Finn, Regev Cohen, Ayelet Grupper, M. Pollard, Amos Toren, Yoram Neumann and Gili Kenet. Their work appears in journals such as Blood, Cancer and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.